Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Targeting bacterial membrane function: an underexploited mechanism for treating persistent infections.

Hurdle JG, O'Neill AJ, Chopra I, Lee RE.

Nat Rev Microbiol. 2011 Jan;9(1):62-75. doi: 10.1038/nrmicro2474. Review.

2.

Bacterial infections: antibiotics and decontamination.

Gould D.

Nurs Stand. 2004 Jun 16-22;18(40):38-42. Review.

PMID:
15224613
3.

Damage to bacteria by antibiotics in vitro and its relevance to antimicrobial chemotherapy: a historical perspective.

Pruul H, McDonald PJ.

J Antimicrob Chemother. 1988 Jun;21(6):695-8. Review. No abstract available.

PMID:
3045065
4.

Targeting non-multiplying organisms as a way to develop novel antimicrobials.

Coates AR, Hu Y.

Trends Pharmacol Sci. 2008 Mar;29(3):143-50. doi: 10.1016/j.tips.2007.12.001. Epub 2008 Feb 11. Review.

PMID:
18262665
5.

Bisphosphocins: novel antimicrobials for enhanced killing of drug-resistant and biofilm-forming bacteria.

Wong JP, DiTullio P, Parkinson S.

Future Microbiol. 2015;10(11):1751-8. doi: 10.2217/fmb.15.70. Review.

6.

Microbiology. Desperately seeking new antibiotics.

Payne DJ.

Science. 2008 Sep 19;321(5896):1644-5. doi: 10.1126/science.1164586. No abstract available.

PMID:
18801989
7.

[Resistance acquisition via the bacterial SOS response: the inducive role of antibiotics].

Da Re S, Ploy MC.

Med Sci (Paris). 2012 Feb;28(2):179-84. doi: 10.1051/medsci/2012282016. Epub 2012 Feb 27. Review. French.

8.

[Principles of local chemotherapeutic infection management].

Hierholzer G.

Aktuelle Probl Chir Orthop. 1979;(12):11-7. German. No abstract available.

PMID:
36769
9.

Persister cells, dormancy and infectious disease.

Lewis K.

Nat Rev Microbiol. 2007 Jan;5(1):48-56. Epub 2006 Dec 4. Review.

PMID:
17143318
10.

Antibiotics and antibiotic resistance genes in natural environments.

Martínez JL.

Science. 2008 Jul 18;321(5887):365-7. doi: 10.1126/science.1159483.

PMID:
18635792
11.

"Nanoantibiotics": a new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era.

Huh AJ, Kwon YJ.

J Control Release. 2011 Dec 10;156(2):128-45. doi: 10.1016/j.jconrel.2011.07.002. Epub 2011 Jul 6. Review.

PMID:
21763369
12.

Persisters and beyond: mechanisms of phenotypic drug resistance and drug tolerance in bacteria.

Kester JC, Fortune SM.

Crit Rev Biochem Mol Biol. 2014 Mar-Apr;49(2):91-101. doi: 10.3109/10409238.2013.869543. Epub 2013 Dec 13. Review.

PMID:
24328927
13.

New antibiotic agents and approaches to treat biofilm-associated infections.

Lynch AS, Abbanat D.

Expert Opin Ther Pat. 2010 Oct;20(10):1373-87. doi: 10.1517/13543776.2010.505923. Review.

PMID:
20636186
14.

Editorial: Molecular determinants of bacterial diseases.

Berisio R.

Curr Med Chem. 2015;22(14):1640-1. No abstract available.

PMID:
25934983
15.

Membrane-Active Small Molecules: Designs Inspired by Antimicrobial Peptides.

Ghosh C, Haldar J.

ChemMedChem. 2015 Oct;10(10):1606-24. doi: 10.1002/cmdc.201500299. Epub 2015 Aug 20. Review.

PMID:
26386345
16.

β-Lactam and glycopeptide antibiotics: first and last line of defense?

Jovetic S, Zhu Y, Marcone GL, Marinelli F, Tramper J.

Trends Biotechnol. 2010 Dec;28(12):596-604. doi: 10.1016/j.tibtech.2010.09.004. Epub 2010 Oct 21. Review.

PMID:
20970210
17.

Controlling bacterial infections by inhibiting proton-dependent processes.

Kaneti G, Meir O, Mor A.

Biochim Biophys Acta. 2016 May;1858(5):995-1003. doi: 10.1016/j.bbamem.2015.10.022. Epub 2015 Oct 30. Review.

PMID:
26522076
18.
19.

What's new on the antimicrobial horizon?

Song JH.

Int J Antimicrob Agents. 2008 Dec;32 Suppl 4:S207-13. doi: 10.1016/S0924-8579(09)70004-4. Review.

PMID:
19134521
20.

Antimicrobial peptides as an opportunity against bacterial diseases.

Galdiero S, Falanga A, Berisio R, Grieco P, Morelli G, Galdiero M.

Curr Med Chem. 2015;22(14):1665-77. Review.

PMID:
25760092

Supplemental Content

Support Center